Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Gender-affirming care greatly improves mental health for transgender and non-binary individuals.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Feminizing hormone therapy increases kidney filtration rate.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Progesterone may help trans women with breast development and health, but more research is needed.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Testosterone treatment may affect heart response to stress in transgender men.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.